Equity · CUSIP 29664W105 · who reports it, how much, and how much it matters to them
26 of the 720 hedge fund managers we track reported shares of Esperion Therapeutics Inc (ESPR) on Form 13F for 30 June 2026. Between them they reported USD 135m. The largest position belongs to Trium Capital LLP, at USD 35m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Trium Capital LLP1 fund on PPLI.com | USD 35m | 21.7% |
| 2 | Two Sigma Investments35 funds on PPLI.com | USD 23m | 0.0% |
| 3 | Balyasny Asset Management25 funds on PPLI.com | USD 15m | 0.0% |
| 4 | TIG Advisors15 funds on PPLI.com | USD 8.2m | 0.4% |
| 5 | Gabelli & Company Investment Advisers17 funds on PPLI.com | USD 7.3m | 1.1% |
| 6 | Millennium Management6 funds on PPLI.com | USD 7m | 0.0% |
| 7 | LMR Partners2 funds on PPLI.com | USD 5.1m | 0.0% |
| 8 | Voleon Capital Management13 funds on PPLI.com | USD 4.9m | 0.1% |
| 9 | Polar Asset Management Partners6 funds on PPLI.com | USD 4.8m | 0.1% |
| 10 | Alpine Associates Management9 funds on PPLI.com | USD 4.7m | 0.3% |
| 11 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 4m | 0.0% |
| 12 | Exoduspoint Capital Management7 funds on PPLI.com | USD 3.6m | 0.0% |
| 13 | Weiss Asset Management5 funds on PPLI.com | USD 2.7m | 0.0% |
| 14 | Water Island Capital1 fund on PPLI.com | USD 1.9m | 0.2% |
| 15 | Verition Fund Management3 funds on PPLI.com | USD 1.6m | 0.0% |
| 16 | Citadel Advisors32 funds on PPLI.com | USD 1.5m | 0.0% |
| 17 | Kintayl Capital2 funds on PPLI.com | USD 1.3m | 0.5% |
| 18 | Burkehill Global Management5 funds on PPLI.com | USD 1.3m | 0.0% |
| 19 | Prelude Capital Management9 funds on PPLI.com | USD 675,000 | 0.0% |
| 20 | Gamco Asset Management1 fund on PPLI.com | USD 545,000 | 0.0% |
| 21 | Renaissance Technologies13 funds on PPLI.com | USD 506,000 | 0.0% |
| 22 | Engineers Gate Manager1 fund on PPLI.com | USD 331,000 | 0.0% |
| 23 | Rangeley Capital6 funds on PPLI.com | USD 196,000 | 0.2% |
| 24 | Mirabella Financial Services LLP10 funds on PPLI.com | USD 118,000 | 0.0% |
| 25 | Boothbay Fund Management2 funds on PPLI.com | USD 94,800 | 0.0% |
| 26 | Marshall Wace LLP84 funds on PPLI.com | USD 44,613 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Trium Capital LLP | USD 35m | 21.7% |
| 2 | Gabelli & Company Investment Advisers | USD 7.3m | 1.1% |
| 3 | Kintayl Capital | USD 1.3m | 0.5% |
| 4 | TIG Advisors | USD 8.2m | 0.4% |
| 5 | Alpine Associates Management | USD 4.7m | 0.3% |
| 6 | Water Island Capital | USD 1.9m | 0.2% |
| 7 | Rangeley Capital | USD 196,000 | 0.2% |
| 8 | Voleon Capital Management | USD 4.9m | 0.1% |
| 9 | Polar Asset Management Partners | USD 4.8m | 0.1% |
| 10 | Prelude Capital Management | USD 675,000 | 0.0% |
Esperion Therapeutics Inc trades under the symbol ESPR. Its CUSIP, the code used on Form 13F, is 29664W105.
26 of the 720 hedge fund managers PPLI.com tracks reported Esperion Therapeutics Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by Trium Capital LLP (USD 35m), Two Sigma Investments (USD 23m), Balyasny Asset Management (USD 15m), TIG Advisors (USD 8.2m) and Gabelli & Company Investment Advisers (USD 7.3m).
26 managers in our coverage reported it, and between them they run 340 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Trium Capital LLP, where the position was 21.7% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Esperion Therapeutics Inc or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.